2021
DOI: 10.1167/tvst.10.10.12
|View full text |Cite
|
Sign up to set email alerts
|

A Second-Generation (44-Channel) Suprachoroidal Retinal Prosthesis: Interim Clinical Trial Results

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

0
33
0

Year Published

2022
2022
2024
2024

Publication Types

Select...
6
2

Relationship

1
7

Authors

Journals

citations
Cited by 36 publications
(45 citation statements)
references
References 59 publications
0
33
0
Order By: Relevance
“…Different neural targets along the visual pathway can be stimulated to elicit flashes of light known as phosphenes, which can be used as rudimentary visual feedback for people with blindness. To date, visual neuroprostheses have been implanted for at least several months in the retina (Humayun et al 2012; Stingl et al 2013; Fujikado et al 2016; Petoe et al 2021; Barnes et al 2016; Palanker et al 2022; Xu et al 2021), optic nerve (Veraart et al 2003), and visual cortex of human subjects (Beauchamp et al 2020; Fernández et al 2021). The Argus® II (Second Sight Medical Products, Sylmar, CA, USA) is a device that was implanted commercially in the United States from 2014 through 2020.…”
Section: Introductionmentioning
confidence: 99%
“…Different neural targets along the visual pathway can be stimulated to elicit flashes of light known as phosphenes, which can be used as rudimentary visual feedback for people with blindness. To date, visual neuroprostheses have been implanted for at least several months in the retina (Humayun et al 2012; Stingl et al 2013; Fujikado et al 2016; Petoe et al 2021; Barnes et al 2016; Palanker et al 2022; Xu et al 2021), optic nerve (Veraart et al 2003), and visual cortex of human subjects (Beauchamp et al 2020; Fernández et al 2021). The Argus® II (Second Sight Medical Products, Sylmar, CA, USA) is a device that was implanted commercially in the United States from 2014 through 2020.…”
Section: Introductionmentioning
confidence: 99%
“…Several approaches to vision restoration with electronic implants exist today (Weiland et al, 2011(Weiland et al, , 2016, including epiretinal (Zhou et al, 2013), subretinal (Palanker et al, 2020), and suprachoroidal (Bareket et al, 2017;Petoe et al, 2021) devices. Each approach has demonstrated the feasibility of partial restoration of visual signals, and in some cases, of useful visually guided behaviors.…”
Section: Discussionmentioning
confidence: 99%
“…This study presents data from four adult human subjects (S1–S4) who participated in the clinical trial of a 44-channel suprachoroidal retinal implant (NCT03406416) between 2018 and 2021. 16 18 The subjects were profoundly blind (bare light perception only) from end-stage retinitis pigmentosa and had the suprachoroidal retinal prosthesis implanted unilaterally in 2018 ( Table 1 ). Device fitting commenced 8 weeks postoperatively, followed by training in laboratory and real-world environments and a minimum of 2 years of regular outcome measure assessments.…”
Section: Methodsmentioning
confidence: 99%
“…Device fitting commenced 8 weeks postoperatively, followed by training in laboratory and real-world environments and a minimum of 2 years of regular outcome measure assessments. 16 18 During this time the subjects used the prosthesis unsupervised in their daily lives and regularly visited the laboratory for training, functional vision assessment, and OCT imaging. Table 1 summarizes the subject demographics and the length of observation for each subject.…”
Section: Methodsmentioning
confidence: 99%
See 1 more Smart Citation